{"DataElement":{"publicId":"6180669","version":"1","preferredName":"Oropharyngeal p16-Negative Cancer AJCC Edition 8 Clinical Tumor T Category","preferredDefinition":"Extent of the primary p16-negative oropharyngeal carcinoma based on information obtained from the date of cancer diagnosis until the start of definitive treatment, or within four months (whichever is shorter), using AJCC Ed.","longName":"OX16N_AJC8_CLN_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6052616","version":"1","preferredName":"Oropharynx Neoplasm CDKN2A-p16 Negative Clinical T Category","preferredDefinition":"The part of the pharynx between the soft palate and the upper portion of the epiglottis._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Indicates that expression of the p16 form of CDKN2A has not been detected in a sample._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"6052651v1.0:6072195v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6052651","version":"1","preferredName":"Oropharynx Neoplasm","preferredDefinition":"The part of the pharynx between the soft palate and the upper portion of the epiglottis.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12762:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharynx","conceptCode":"C12762","definition":"The part of the pharynx between the soft palate and the upper portion of the epiglottis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630C1054-6248-5BD4-E053-F662850A4B08","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6072195","version":"1","preferredName":"CDKN2A-p16 Negative Clinical T Category","preferredDefinition":"Indicates that expression of the p16 form of CDKN2A has not been detected in a sample.:Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C132226:C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A-p16 Negative","conceptCode":"C132226","definition":"Indicates that expression of the p16 form of CDKN2A has not been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65367177-B490-7A34-E053-F662850A28B5","latestVersionIndicator":"Yes","beginDate":"2018-02-15","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-15","modifiedBy":"ONEDATA","dateModified":"2018-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"62FB6C79-9A29-02D5-E053-F662850A1789","latestVersionIndicator":"Yes","beginDate":"2018-01-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-17","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt released. 1/17/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6052667","version":"1","preferredName":"Oropharyngeal (p16-Negative) Carcinoma American Joint Committee on Cancer Edition 8 T Category","preferredDefinition":"A finding about one or more characteristics of p16-negative oropharyngeal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to p16-negative squamous cell carcinomas of the oropharynx, oropharyngeal cancers without p16 immunostaining performed, minor salivary gland carcinomas of the oropharynx, and neuroendocrine carcinomas of the oropharynx. Oropharyngeal cancers which are p16-positive are staged according to the classification for p16-positive oropharyngeal cancers. (from AJCC 8th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"6052667v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4b","valueDescription":"Oropharyngeal (p16-Negative) Cancer pT4b TNM Finding v8","ValueMeaning":{"publicId":"6052673","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pT4b TNM Finding v8","longName":"6052673","preferredDefinition":"Oropharyngeal (p16-negative) cancer with very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pT4b TNM Finding v8","conceptCode":"C132925","definition":"Oropharyngeal (p16-negative) cancer with very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-842A-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630D1355-8443-6006-E053-F662850AB146","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"TX","valueDescription":"Oropharyngeal (p16-Negative) Cancer pTX TNM Finding v8","ValueMeaning":{"publicId":"6052669","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pTX TNM Finding v8","longName":"6052669","preferredDefinition":"Oropharyngeal (p16-negative) cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pTX TNM Finding v8","conceptCode":"C132916","definition":"Oropharyngeal (p16-negative) cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-83DE-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630D1355-83F7-6006-E053-F662850AB146","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Oropharyngeal (p16-Negative) Cancer pTis TNM Finding v8","ValueMeaning":{"publicId":"6052671","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pTis TNM Finding v8","longName":"6052671","preferredDefinition":"Oropharyngeal (p16-negative) cancer with a finding of carcinoma in situ. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pTis TNM Finding v8","conceptCode":"C132917","definition":"Oropharyngeal (p16-negative) cancer with a finding of carcinoma in situ. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-8404-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630D1355-841D-6006-E053-F662850AB146","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Oropharyngeal (p16-Negative) Cancer pT4a TNM Finding v8","ValueMeaning":{"publicId":"6052675","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pT4a TNM Finding v8","longName":"6052675","preferredDefinition":"Oropharyngeal (p16-negative) cancer with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pT4a TNM Finding v8","conceptCode":"C132924","definition":"Oropharyngeal (p16-negative) cancer with moderately advanced local disease. Tumor invades the larynx, extrinsic muscle of tongue, medial pterygoid, hard palate, or mandible. Mucosal extension to lingual surface of epiglottis from primary tumors of the base of the tongue and vallecula does not constitute invasion of the larynx. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-8450-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630D1355-8469-6006-E053-F662850AB146","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"T4","valueDescription":"Oropharyngeal (p16-Negative) Cancer pT4 TNM Finding v8","ValueMeaning":{"publicId":"6052677","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pT4 TNM Finding v8","longName":"6052677","preferredDefinition":"Oropharyngeal (p16-negative) cancer with moderately advanced or very advanced local disease. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pT4 TNM Finding v8","conceptCode":"C132922","definition":"Oropharyngeal (p16-negative) cancer with moderately advanced or very advanced local disease. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-8476-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630D1355-848F-6006-E053-F662850AB146","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"T3","valueDescription":"Oropharyngeal (p16-Negative) Cancer pT3 TNM Finding v8","ValueMeaning":{"publicId":"6052679","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pT3 TNM Finding v8","longName":"6052679","preferredDefinition":"Oropharyngeal (p16-negative) cancer with tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pT3 TNM Finding v8","conceptCode":"C132920","definition":"Oropharyngeal (p16-negative) cancer with tumor larger than 4 cm in greatest dimension or extension to lingual surface of epiglottis. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-849C-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630D1355-84B5-6006-E053-F662850AB146","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"T2","valueDescription":"Oropharyngeal (p16-Negative) Cancer pT2 TNM Finding v8","ValueMeaning":{"publicId":"6052681","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pT2 TNM Finding v8","longName":"6052681","preferredDefinition":"Oropharyngeal (p16-negative) cancer with tumor larger than 2 cm but not larger than 4 cm in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pT2 TNM Finding v8","conceptCode":"C132919","definition":"Oropharyngeal (p16-negative) cancer with tumor larger than 2 cm but not larger than 4 cm in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-84C2-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630D1355-84DB-6006-E053-F662850AB146","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"},{"value":"T1","valueDescription":"Oropharyngeal (p16-Negative) Cancer pT1 TNM Finding v8","ValueMeaning":{"publicId":"6052683","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer pT1 TNM Finding v8","longName":"6052683","preferredDefinition":"Oropharyngeal (p16-negative) cancer with tumor 2 cm or smaller in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer pT1 TNM Finding v8","conceptCode":"C132918","definition":"Oropharyngeal (p16-negative) cancer with tumor 2 cm or smaller in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-84E8-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"630D1355-8501-6006-E053-F662850AB146","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6052666","version":"1","preferredName":"Oropharyngeal (p16-Negative) Cancer TNM Finding v8 American Joint Committee on Cancer T Category Category","preferredDefinition":"A finding about one or more characteristics of p16-negative oropharyngeal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to p16-negative squamous cell carcinomas of the oropharynx, oropharyngeal cancers without p16 immunostaining performed, minor salivary gland carcinomas of the oropharynx, and neuroendocrine carcinomas of the oropharynx. Oropharyngeal cancers which are p16-positive are staged according to the classification for p16-positive oropharyngeal cancers. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C132909:C39315:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal (p16-Negative) Cancer TNM Finding v8","conceptCode":"C132909","definition":"A finding about one or more characteristics of p16-negative oropharyngeal cancer, following the rules of the TNM AJCC v8 classification system. This staging system applies to p16-negative squamous cell carcinomas of the oropharynx, oropharyngeal cancers without p16 immunostaining performed, minor salivary gland carcinomas of the oropharynx, and neuroendocrine carcinomas of the oropharynx. Oropharyngeal cancers which are p16-positive are staged according to the classification for p16-positive oropharyngeal cancers. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"630D1355-83B1-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"ONEDATA","dateModified":"2018-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"630D1355-83C2-6006-E053-F662850AB146","latestVersionIndicator":"Yes","beginDate":"2018-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-01-18","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt released. 1/18/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6052641","version":"1","longName":"Oropharyngeal","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Clinical T category","type":"Preferred Question Text","description":"Clinical T category","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"69693636-EA27-1CFD-E053-F662850AC9D6","latestVersionIndicator":"Yes","beginDate":"2018-04-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-04-09","modifiedBy":"TAYLORT","dateModified":"2018-04-09","changeDescription":"4/9/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}